The midterms highlighted the negative sentiment around AI across the U.S. How will those attitudes trickle down to ...

Massachusetts voters decisively shot down a ballot initiative that would have dismantled the state’s recreational cannabis ...

MAHA was already fracturing over issues like pesticides, and factored little into key races.  Now it must contend with a big ...

Democratic physicians, nurses, and scientists won dramatic victories across the U.S. on Tuesday, part of the sweeping blue ...

The Democratic flip of the Senate is expected to put two Democrats who support Medicare for All in charge of key committees.

WASHINGTON — Democrats broke the Republican trifecta of power in Washington Tuesday night, securing powerful new tools to ...

This is the web edition of STAT’s AI Prognosis newsletter, our guide to artificial intelligence in health care and medicine.

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...

The FDA gave tentative approval to Dr. Reddy’s Laboratories to make a generic version of a groundbreaking HIV prevention ...

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and ...

MRT is not legal in the U.S. But medical tourism agencies charge thousands of dollars to connect women to clinics around the ...